Cardioversion of persistent atrial fibrillation by a combination of atrial specific and non-specific class III drugs in the goat.
暂无分享,去创建一个
U Schotten | M. Allessie | U. Schotten | H. Neuberger | Y. Blaauw | A. van Hunnik | M A Allessie | Y Blaauw | A van Hunnik | H R Neuberger
[1] S Nattel,et al. Evidence for two components of delayed rectifier K+ current in human ventricular myocytes. , 1996, Circulation research.
[2] K. Ellenbogen,et al. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators. , 1996, Circulation.
[3] P. Kowey,et al. Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation. , 1998, Journal of the American College of Cardiology.
[4] D. Roden,et al. Quinidine delays IK activation in guinea pig ventricular myocytes. , 1988, Circulation research.
[5] Mark A. Wood,et al. Efficacy and Safety of Repeated Intravenous Doses of Ibutilide for Rapid Conversion of Atrial Flutter or Fibrillation , 1996 .
[6] Bertram Pitt,et al. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction , 1996, The Lancet.
[7] U Schotten,et al. “Early” Class III Drugs for the Treatment of Atrial Fibrillation: Efficacy and Atrial Selectivity of AVE0118 in Remodeled Atria of the Goat , 2004, Circulation.
[8] S Nattel,et al. Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. , 1997, Circulation research.
[9] I. V. Van Gelder,et al. Safe and effective conversion of persistent atrial fibrillation to sinus rhythm by intravenous AZD7009. , 2006, Heart rhythm.
[10] M. Allessie,et al. Consequences of atrial electrical remodeling for the anti-arrhythmic action of class IC and class III drugs. , 2005, Cardiovascular research.
[11] J. Nerbonne. Molecular basis of functional voltage‐gated K+ channel diversity in the mammalian myocardium , 2000, The Journal of physiology.
[12] K. Stangl,et al. Superiority of ibutilide (a new class III agent) overdl-sotalol in converting atrial flutter and atrial fibrillation , 1998, Heart.
[13] M. Allessie,et al. Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat: effects of cibenzoline, hydroquinidine, flecainide, and d-sotalol. , 2000, Circulation.
[14] S. Nattel,et al. Cardiac Ultrarapid Delayed Rectifiers , 1999, Cellular Physiology and Biochemistry.
[15] A. Waldo,et al. Azd7009: a new antiarrhythmic drug with predominant effects on the atria effectively terminates and prevents reinduction of atrial fibrillation and flutter in the sterile pericarditis model. , 2004, Journal of cardiovascular electrophysiology.
[16] I. Stiell,et al. A randomized, controlled trial of RSD1235, a novel anti-arrhythmic agent, in the treatment of recent onset atrial fibrillation. , 2004, Journal of the American College of Cardiology.
[17] R. Sah,et al. Targeted expression of a dominant-negative K(v)4.2 K(+) channel subunit in the mouse heart. , 1999, Circulation research.
[18] M. Allessie,et al. Automatic mapping of human atrial fibrillation by template matching. , 2006, Heart rhythm.
[19] J. L. Kenyon,et al. 4-Aminopyridine and the early outward current of sheep cardiac Purkinje fibers , 1979, The Journal of general physiology.
[20] C. Lau,et al. Electrophysiologic actions of dl-sotalol in patients with persistent atrial fibrillation. , 2002, Journal of the American College of Cardiology.
[21] D. Dobrev,et al. Role of IKur in Controlling Action Potential Shape and Contractility in the Human Atrium: Influence of Chronic Atrial Fibrillation , 2004, Circulation.
[22] P. Volders,et al. Atrial-specific drug AVE0118 is free of torsades de pointes in anesthetized dogs with chronic complete atrioventricular block. , 2006, Heart rhythm.
[23] D. Fedida,et al. The Mechanism of Atrial Antiarrhythmic Action of RSD1235 , 2005, Journal of cardiovascular electrophysiology.
[24] S Nattel,et al. Ionic targets for drug therapy and atrial fibrillation-induced electrical remodeling: insights from a mathematical model. , 1999, Cardiovascular research.
[25] M. Bleich,et al. Effects of the atrial antiarrhythmic drug AVE0118 on cardiac ion channels , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.
[26] M. Allessie,et al. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. , 1995, Circulation.